Showing results (71-80 of 305) with videos related to

Sort By:
Pageof 31
Cancer|August 24, 2005
Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myelomaAntonio Palumbo, Alessandra Bertola, Pellegrino Musto, et al.
European Journal of Haematology|November 29, 2016
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myelomaMassimo Offidani, Laura Corvatta, Sara Bringhen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 24, 2017
Over- and under-prophylaxis for chemotherapy-induced (febrile) neutropenia relative to evidence-based guidelines is associated with differences in outcomes: findings from the MONITOR-GCSF studyCarsten Bokemeyer, Pere Gascón, Matti Aapro, et al.
BMC Bioinformatics|November 25, 2017
HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing dataMarco Beccuti, Elisa Genuardi, Greta Romano, et al.
Journal of Geriatric Oncology|November 11, 2016
Chemotherapy-induced (febrile) neutropenia prophylaxis with biosimilar filgrastim in elderly versus non-elderly cancer patients: Patterns, outcomes, and determinants (MONITOR-GCSF study)Matti Aapro, Carsten Bokemeyer, Heinz Ludwig, et al.
Journal of Hematology & Oncology|January 15, 2017
Can pegylated interferon improve the outcome of polycythemia vera patients?Elena Crisà, Marco Cerrano, Eloise Beggiato, et al.
Cancer|June 28, 2007
Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapyAntonio Palumbo, Sara Bringhen, Patrizia Falco, et al.
Medical Oncology (Northwood, London, England)|October 5, 2006
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remissionIgnazio Majolino, Marco Ladetto, Anna Locasciulli, et al.
Expert Review of Anticancer Therapy|October 18, 2008
Role of thalidomide in previously untreated patients with multiple myelomaPellegrino Musto, Fiorella D'Auria, Giuseppe Pietrantuono, et al.
Haematologica|August 6, 2002
Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myelomaMario Boccadoro, Antonio Palumbo, Sara Bringhen, et al.
Pageof 31